Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$89.33 n/a | n/a%
07/22/14 - 03:59 PM ET
Ratio Comparisons
Company Industry S&P 500
Valuation Ratios
P/E Ratio (TTM) 32.10 n.a. 28.87
P/E High - Last 5 Yrs 47.00 n.a. 42.76
P/E Low - Last 5 Yrs 9.60 n.a. 9.56
Beta 0.71 0.95 1.09
Price to Sales (TTM) 9.77 9.83 2.89
Price to Book (MRQ) 9.98 7.56 4.77
Price to Tangible Book (MRQ) 263.04 32.24 7.28
Price to Cash Flow (TTM) 26.30 70.70 19.20
Price to Free Cash Flow (TTM) 36.30 -52.10 18.01
Dividends
Dividend Yield (%) 0.00 0.40 1.82
Dividend Yield - 5 Yr Avg (%) n.a. 0.20 2.44
Dividend 5 Yr Growth Rate (%) n.a. 31.86 13.10
Payout Ratio (TTM) 0.00 n.a. 45.03
Sales (MRQ) vs Qtr 1 Yr Ago (%) 97.50 41.90 6.91
Sales (TTM) vs TTM 1 Yr Ago (%) 15.50 16.10 5.65
Growth Rates (%)
Sales - 5 Yr Growth Rate (%) 13.84 6.16 6.73
EPS (MRQ) vs Qtr 1 Yr Ago (%) 209.70 64.70 66.69
EPS (TTM) vs TTM 1 Yr Ago (%) 209.70 64.70 66.69
EPS - 5 Yr Growth Rate (%) 5.97 n.a. 10.45
Capital Spending - 5 Yr Growth Rate (%) 54.21 23.13 9.81
Financial Strength
Quick Ratio (MRQ) 1.60 2.60 1.29
Current Ratio (MRQ) 2.20 3.10 1.94
LT Debt to Equity (MRQ) 0.59 0.59 1.01
Total Debt to Equity (MRQ) 0.73 0.68 1.17
Interest Coverage (TTM) 21.60 5.60 59.09
Profitability Ratios (%)
Gross Margin (TTM) 81.50 87.70 47.23
Gross Margin - 5 Yr Avg 78.50 85.90 46.66
EBITD Margin (TTM) 51.60 22.90 25.52
EBITD - 5 Yr Avg 49.25 0.00 0.00
Pre-Tax Margin (TTM) 45.50 13.00 15.56
Pre-Tax Margin - 5 Yr Avg 42.70 14.20 13.91
Management Effectiveness (%)
Net Profit Margin (TTM) 33.40 7.61 9.21
Net Profit Margin - 5 Yr Avg 31.50 9.70 10.60
Return on Assets (TTM) 16.20 2.40 6.85
Return on Assets - 5 Yr Avg 16.90 3.90 6.46
Return on Investment (TTM) 21.40 3.20 11.90
Return on Investment - 5 Yr Avg 22.30 5.20 11.07
Efficiency
Revenue/Employee (TTM) 2,240,821.00 798,948.00 936,743.26
Net Income/Employee (TTM) 747,896.00 53,376.00 112,731.59
Receivable Turnover (TTM) 5.30 5.90 14.83
Inventory Turnover (TTM) 1.30 1.10 19.07
Asset Turnover (TTM) 0.50 0.40 0.80

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases

Partner Headlines for GILD

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter